Overview
Congenital or early infantile CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) is the most severe form of vanishing white matter disease (VWM), also known as leukoencephalopathy with vanishing white matter. This form presents at birth or within the first year of life and follows a rapidly progressive course. It is caused by biallelic pathogenic variants in one of the five genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1, EIF2B2, EIF2B3, EIF2B4, or EIF2B5). These genes are essential for protein synthesis in all cells, but the brain's white matter is particularly vulnerable, leading to progressive destruction and cystic degeneration of cerebral white matter. The congenital and early infantile forms represent the most severe end of the VWM disease spectrum. Affected infants may present with severe neurological decline from birth, including progressive spasticity, cerebellar ataxia, seizures, feeding difficulties, and failure to thrive. Congenital cases may show additional features such as cataracts, hepatosplenomegaly, renal abnormalities, and ovarian dysgenesis (in females). Brain MRI characteristically shows diffuse white matter abnormalities with areas of cystic degeneration and rarefaction, giving the appearance of 'vanishing' white matter. Neurological deterioration is often rapid and can be triggered or worsened by febrile infections, minor head trauma, or other physiological stressors. There is currently no cure or disease-modifying treatment for congenital or early infantile CACH syndrome. Management is supportive and symptomatic, focusing on seizure control, nutritional support, physical therapy, and prevention of known triggers of neurological deterioration such as fever and infections. The prognosis for this severe form is poor, with most affected children experiencing rapid neurological decline and significantly shortened life expectancy, often dying within the first few years of life. Genetic counseling is recommended for affected families.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital or early infantile CACH syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital or early infantile CACH syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Congenital or early infantile CACH syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital or early infantile CACH syndrome.
Community
No community posts yet. Be the first to share your experience with Congenital or early infantile CACH syndrome.
Start the conversation →Latest news about Congenital or early infantile CACH syndrome
No recent news articles for Congenital or early infantile CACH syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital or early infantile CACH syndrome
What is Congenital or early infantile CACH syndrome?
Congenital or early infantile CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) is the most severe form of vanishing white matter disease (VWM), also known as leukoencephalopathy with vanishing white matter. This form presents at birth or within the first year of life and follows a rapidly progressive course. It is caused by biallelic pathogenic variants in one of the five genes encoding subunits of the eukaryotic translation initiation factor 2B (EIF2B1, EIF2B2, EIF2B3, EIF2B4, or EIF2B5). These genes are essential for protein synthesis in all cells, but the brain's
How is Congenital or early infantile CACH syndrome inherited?
Congenital or early infantile CACH syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital or early infantile CACH syndrome typically begin?
Typical onset of Congenital or early infantile CACH syndrome is neonatal. Age of onset can vary across affected individuals.